These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 25925613

  • 21. Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma.
    Badr S, Kotb M, Elahmadawy MA, Moustafa H.
    Clin Nucl Med; 2018 Dec; 43(12):e428-e438. PubMed ID: 30358625
    [Abstract] [Full Text] [Related]

  • 22. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
    Mittal BR, Manohar K, Malhotra P, Das R, Kashyap R, Bhattacharya A, Varma N, Varma S.
    Leuk Lymphoma; 2011 Nov; 52(11):2111-6. PubMed ID: 21745169
    [Abstract] [Full Text] [Related]

  • 23. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
    Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, Moser E, Glatting G, Kotzerke J, Guhlmann CA, Schirrmeister H, Reske SN.
    Cancer; 2001 Mar 01; 91(5):889-99. PubMed ID: 11251940
    [Abstract] [Full Text] [Related]

  • 24. Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients.
    Cheng G, Chen W, Chamroonrat W, Torigian DA, Zhuang H, Alavi A.
    Eur J Nucl Med Mol Imaging; 2011 Aug 01; 38(8):1469-76. PubMed ID: 21505896
    [Abstract] [Full Text] [Related]

  • 25. [Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration].
    Tang R, Gui S, Li J, Zhang H, Lu B, Yang P, Fu D, Fu W, Li W, Cai L.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar 01; 35(3):231-5. PubMed ID: 24666490
    [Abstract] [Full Text] [Related]

  • 26. Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma.
    Xiao-Xue W, Xinyue H, Lijun Z.
    Med Clin (Barc); 2020 Jan 24; 154(2):61-65. PubMed ID: 31757394
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Kandeel AA, Hussein M, Zidan L, Younis J, Edesa W, Alsayed Y.
    Nucl Med Commun; 2020 Mar 24; 41(3):269-279. PubMed ID: 31895758
    [Abstract] [Full Text] [Related]

  • 28. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.
    Cerci JJ, Trindade E, Buccheri V, Fanti S, Coutinho AM, Zanoni L, Linardi CC, Celli M, Delbeke D, Pracchia LF, Pitela FA, Soares J, Zinzani PL, Meneghetti JC.
    Clin Lymphoma Myeloma Leuk; 2011 Aug 24; 11(4):314-20. PubMed ID: 21816369
    [Abstract] [Full Text] [Related]

  • 29. Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.
    Puccini B, Nassi L, Minoia C, Volpetti S, Ciancia R, Riccomagno PC, Di Rocco A, Mulè A, Toldo C, Sassone MC, Guariglia R, Filì C, Finolezzi E, Falorio S, Zanon S, Furlan A, Doa G, Zaja F, Fondazione Italiana Linfomi Postgraduate Master course.
    Ann Hematol; 2017 Jul 24; 96(7):1147-1153. PubMed ID: 28451805
    [Abstract] [Full Text] [Related]

  • 30. Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma.
    Cistaro A, Cassalia L, Ferrara C, Quartuccio N, Evangelista L, Bianchi M, Fagioli F, Bisi G, Baldari S, Zanella A, Pillon M, Zucchetta P, Burei M, Sala A, Guerra L, Guglielmo P, Burnelli R, Panareo S, Scalorbi F, Rambaldi I, Piccardo A, Garaventa A, Familiari D, Fornito MC, Lopci E, Mascarin M, Altini C, Ferrari C, Perillo T, Santoro N, Borsatti E, Rubini G.
    Clin Lymphoma Myeloma Leuk; 2018 Jun 24; 18(6):e267-e273. PubMed ID: 29739722
    [Abstract] [Full Text] [Related]

  • 31. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D, Patti C, Lagalla R, Midiri M, Galia M.
    J Magn Reson Imaging; 2017 Apr 24; 45(4):1082-1089. PubMed ID: 27603267
    [Abstract] [Full Text] [Related]

  • 32. Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study.
    Hamilton R, Andrews I, McKay P, Leach M.
    Leuk Lymphoma; 2014 May 24; 55(5):1049-52. PubMed ID: 23915196
    [Abstract] [Full Text] [Related]

  • 33. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF, Chang CC, Liu YC, Chang CS, Hsiao HH, Liu TC, Huang CT, Lin SF.
    Kaohsiung J Med Sci; 2015 Mar 24; 31(3):130-7. PubMed ID: 25744235
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
    Zhou Z, Chen C, Li X, Li Z, Zhang X, Chang Y, Lu L, Cui Y, Ma Y, Zhang M.
    Ann Hematol; 2015 Jun 24; 94(6):963-7. PubMed ID: 25547320
    [Abstract] [Full Text] [Related]

  • 35. [Diagnostic and Prognostic Value of 18F-FDG PET/CT in Bone Marrow Infiltration of Newly Diagnosed Diffuse Large B-Cell Lymphoma].
    Chen X, Qiao WL, Song JH, Liu CC, Han L, Wu S, Zhao JH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug 24; 31(4):1044-1049. PubMed ID: 37551475
    [Abstract] [Full Text] [Related]

  • 36. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
    Hong J, Lee Y, Park Y, Kim SG, Hwang KH, Park SH, Jeong J, Kim KH, Ahn JY, Park S, Park J, Lee JH.
    Ann Hematol; 2012 May 24; 91(5):687-695. PubMed ID: 22008868
    [Abstract] [Full Text] [Related]

  • 37. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
    Ribrag V, Vanel D, Leboulleux S, Lumbroso J, Couanet D, Bonniaud G, Aupérin A, Masson F, Bosq J, Edeline V, Fermé C, Pigneur F, Schlumberger M.
    Eur J Radiol; 2008 May 24; 66(2):325-31. PubMed ID: 17651934
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
    Chen S, Wang S, He K, Ma C, Fu H, Wang H.
    Eur Radiol; 2018 Jul 24; 28(7):2942-2950. PubMed ID: 29383519
    [Abstract] [Full Text] [Related]

  • 40. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
    Muslimani AA, Farag HL, Francis S, Spiro TP, Chaudhry AA, Chan VC, Taylor HC, Daw HA.
    Am J Clin Oncol; 2008 Oct 24; 31(5):409-12. PubMed ID: 18838874
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.